ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells

Hadi Karami, Behzad Baradaran*, Ali Esfahani, Masoud Sakhinia, Ebrahim Sakhinia*

Adv Pharm Bull. 2014;4(3): 243-248. doi: 10.5681/apb.2014.035

PMCID: PMC3992959 PMID: 24754007 Scopus ID: 84983573919

Article

PDF

XML

Cited By:

Short Communication

2. The Effects of Hypoxia on U937 Cell Line in Mesenchymal Stem Cells Co-Culture System

Mostafa Ejtehadifar, Karim Shamsasenjan, Parvin Akbarzadehlaleh*, Sarah Zahedi, Narjes Kazemi

Adv Pharm Bull. 2016;6(4): 645-650. doi: 10.15171/apb.2016.079

PMCID: PMC5241423 PMID: 28101472 Scopus ID: 85011357346

Article

PDF

XML

Cited By:

Short Communication

3. 10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 Arrest

Andrea Rasmussen , Kaylee Murphy, David W. Hoskin*

Adv Pharm Bull. 2019;9(4): 685-689. doi: 10.15171/apb.2019.080

PMCID: PMC6912173 PMID: 31857975 Scopus ID: 85075838080

Article

PDF

XML

Cited By:

Research Article

4. Effect of Mineral Pitch on the Proliferation of Human Adipose Derived Stem Cells on Acellular Scaffold

Hossein Taghavi , Jafar Soleimani Rad, Ahmad Mehdipour, Ahad Ferdosi Khosroshahi, Raziyeh Kheirjou, Milad Hasanpour, Leila Roshangar*

Adv Pharm Bull. 2020;10(4): 623-629. doi: 10.34172/apb.2020.075

PMCID: PMC7539320 PMID: 33072541 Scopus ID: 85090435510

Article

PDF

Full Text

XML

Cited By:

Research Article

5. miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1

Solmaz Shirjang , Behzad Mansoori, Ali Mohammadi, Neda Shajari, Pascal H.G. Duijf, Souzan Najafi, Fereydoon Abedi Gaballu, Katayoon Nofouzi, Behzad Baradaran*

Adv Pharm Bull. 2020;10(3): 444-451. doi: 10.34172/apb.2020.054

PMCID: PMC7335988 PMID: 32665904 Scopus ID: 85088614001

Article

PDF

Full Text

XML

Cited By:

Research Article

6. Restoring of miR-193a-5p Sensitizes Breast Cancer Cells to Paclitaxel through P53 Pathway

Monireh Khordadmehr* , Roya Shahbazi, Behzad Baradaran*, Sanam Sadreddini, Dariush Shanebandi, Khalil Hajiasgharzadeh

Adv Pharm Bull. 2020;10(4): 595-601. doi: 10.34172/apb.2020.071

PMCID: PMC7539307 PMID: 33072537 Scopus ID: 85090475121

Article

PDF

Full Text

XML

Cited By:

Review Article

7. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics

Gul-e-Saba Chaudhry* , Abdah Akim, Muhammad Naveed Zafar, Naila Safdar, Yeong Yik Sung, Tengku Sifzizul Tengku Muhammad

Adv Pharm Bull. 2021;11(3): 426-438. doi: 10.34172/apb.2021.050

PMCID: PMC8421618 PMID: 34513617 Scopus ID: 85108917744

Article

PDF

Full Text

XML

Cited By:

Research Article

8. Restoration of miRNA-143 Expression Inhibits Growth and Migration of MKN-45 Gastric Cancer Cell Line

Nayer Hosseinahli , Tahereh Zeinali, Nasrin Hosseinahli, Leila Karimi, Dariush Shanehbandi, Behzad Mansoori, Ali Mohammadi, Tohid Kazemi, Khalil Hajiasgharzadeh, Behzad Baradaran*

Adv Pharm Bull. 2022;12(1): 183-190. doi: 10.34172/apb.2022.020

PMCID: PMC9012916 PMID: 35517885 Scopus ID: 85127122645

Article

PDF

Full Text

XML

Cited By:

Research Article

9. Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation

Mohammad A.Y. Alqudah* , Marwah Azaizeh, Aref Zayed, Leen Asaad

Adv Pharm Bull. 2022;12(2): 383-388. doi: 10.34172/apb.2022.037

PMCID: PMC9106957 PMID: 35620345 Scopus ID: 85128189987

Article

PDF

Full Text

XML

Cited By:

Research Article

10. MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study

Leila Tebbi , Behzad Mansoori, Sahar Safaei, Shahriar Hashemzadeh, Masoud Shirmohamadi, Khalil Hajiasgharzadeh, Mahdi Abdoli Shadbad, Behzad Baradaran*

Adv Pharm Bull. 2022;12(4): 842-849. doi: 10.34172/apb.2022.083

PMCID: PMC9675915 PMID: 36415628 Scopus ID: 85140272177

Article

PDF

Full Text

XML

Cited By:

Editorial

11. Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression

Amr Ahmed , Maher Monir. Akl*

Adv Pharm Bull. 2024;14(2): 262-265. doi: 10.34172/apb.2024.040

PMCID: PMC11347740 PMID: 39206389

Article

PDF

Full Text

XML

Cited By: